Benazepril hydrochloride 20 mg tablets for dogs
Benazepril hydrochloride 20 mg tablets for dogs
Authorised
- Benazepril hydrochloride
Product identification
Medicine name:
Benazepril hydrochloride 20 mg tablets for dogs
Active substance:
- Benazepril hydrochloride
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Benazepril hydrochloride20.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC09AA07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Package description:
- Carton box containing 6 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 7 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 6 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 5 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 7 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 4 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 4 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 3 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 2 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
- Carton box containing 1 PVC-PE-PVDC-Alu-foil blisters of 14 tablets
- Carton box containing 2 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 1 Alu-Alu-foil blisters blisters of 14 tablets
- Carton box containing 5 Alu-Alu -foil blisters blisters of 14 tablets each
- Carton box containing 3 PVC-PE-PVDC-Alu-foil blisters of 14 tablets each
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 401022.01.00
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0125/003
Concerned member states:
-
Denmark
-
Germany
-
Greece
-
Hungary
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
